| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Trishna Goswami last filed a Form 4 in September 2024, as Chief Medical Officer at INAB. Trishna Goswami's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 6,729 shares of INAB. Net of sales, the INAB filings show accumulation of 2,631 shares.
Trishna Goswami has 9 Form 4 filings on record from November 2021 to September 2024, all as Chief Medical Officer at IN8BIO (INAB), 2021–2024.
The 11 reported transactions were 9 option or other derivative awards, 1 stock award and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $5K and no sales.
The only open-market purchase was 2,631 shares of INAB at an average $1.90 on August 16, 2022, about $5K. Twelve months later INAB was down 37%.
Shares as reported in the last Form 4 for each company; the most recent is from September 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | INAB In8bio, Inc. | Chief Medical Officer | Buy | 2,631 | $1.90 | $4,998.90 | New | -19.6% | -37.0% |